Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

LogiCamms Wins AUD$8.3 Million Rio Tinto Electrical Contract

Legend Mining to Sell Mt Gibson Gold Project to Top Iron

Manitou Gold Announces Drilling at Gaffney Extension Project

Nevada Copper Announces Positive Step-Out Hole Results from Pumpkin Hollow Property

Banks Island Gold Receives Gold Assays from Tel Zone

New Mining Bill to Cost Says Department of Natural Resources

Grand Canyon Gets Protection from Mining for 20 Years

Gina Rinehart Appoints Daughter Ginia to Board

Polymetals Mining to Take Up 50% of Drew Hill Project‎, South Australia

Aurora Algae to Bring Biofuel Business to Australia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.